Cargando…
The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204360/ https://www.ncbi.nlm.nih.gov/pubmed/35713667 http://dx.doi.org/10.1007/s00134-022-06768-0 |
| _version_ | 1784728908947521536 |
|---|---|
| author | Hofmaenner, Daniel A. Singer, Mervyn |
| author_facet | Hofmaenner, Daniel A. Singer, Mervyn |
| author_sort | Hofmaenner, Daniel A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9204360 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92043602022-06-17 The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply Hofmaenner, Daniel A. Singer, Mervyn Intensive Care Med Correspondence Springer Berlin Heidelberg 2022-06-17 2022 /pmc/articles/PMC9204360/ /pubmed/35713667 http://dx.doi.org/10.1007/s00134-022-06768-0 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Hofmaenner, Daniel A. Singer, Mervyn The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title | The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title_full | The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title_fullStr | The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title_full_unstemmed | The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title_short | The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply |
| title_sort | challenge of pharmacological thromboprophylaxis in icu patients: anti-fxa activity does not constitute the simple solution. author's reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204360/ https://www.ncbi.nlm.nih.gov/pubmed/35713667 http://dx.doi.org/10.1007/s00134-022-06768-0 |
| work_keys_str_mv | AT hofmaennerdaniela thechallengeofpharmacologicalthromboprophylaxisinicupatientsantifxaactivitydoesnotconstitutethesimplesolutionauthorsreply AT singermervyn thechallengeofpharmacologicalthromboprophylaxisinicupatientsantifxaactivitydoesnotconstitutethesimplesolutionauthorsreply AT hofmaennerdaniela challengeofpharmacologicalthromboprophylaxisinicupatientsantifxaactivitydoesnotconstitutethesimplesolutionauthorsreply AT singermervyn challengeofpharmacologicalthromboprophylaxisinicupatientsantifxaactivitydoesnotconstitutethesimplesolutionauthorsreply |